388 followers
Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor /Factor VIII Concentrate in #Pediatric Patients <12 Years of Age with Hemophilia A https://t.co/b40wkdnqeS #openaccess